CERVICAL SCREENING FOR GENITOURINARY SYNDROME OF MENOPAUSE
- Authors: Kliryshkova T.1, Samosudova I.1, Mironova O.1
-
Affiliations:
- Issue: Vol 28, No 8 (2017)
- Pages: 14-17
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116891
- ID: 116891
Cite item
Open Access
Access granted
Abstract
The cervical cytological and colposcopic characteristics depending on the phase of the climacteric (peri- and postmenopausal) period, which have been established in the comprehensive examination of patients with genitourinary syndrome of menopause, justify the use of local estrogen therapy.
Full Text
About the authors
T. Kliryshkova
Email: klin_tatyana@mail.ru
Professor MD Omsk State Medical University Omsk
I. Samosudova
Candidate of Medical Sciences Ultramed Clinical and Diagnostic Center Omsk
O. Mironova
Clinical Diagnostic Center Omsk
References
- Portman D., Gass M. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society // Maturitas. - 2014; 79 (3): 349-54.
- Аполихина И.А., Горбунова Е.А. Клинико-морфологические аспекты вульвовагинальной атрофии // Мед. совет. - 2014; 9: 110-7.
- Kim H., Kang S., Chung Y. et al. The Recent Review of the Genitourinary Syndrome of Menopause // J. Menopausal. Med. - 2015; 21 (2): 65-71.
- Goldstein I., Dicks B., Kim N. et al. Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women // Sex Med. - 2013; 1 (2): 44-53.
- Parish S., Nappi R., Krychman M. et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy // Int. J. Womens Health. - 2013; 5: 437-47.
- DiBonaventura M., Luo X., Moffatt M. et al. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe // J. Womens Health (Larchmt). -2015; 24 (9): 713-22.
- Kingsberg S., Kellogg S., Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy // Int. J. Womens Health. - 2009; 1: 105-11.
- Клинышкова Т.В., Самосудова И.Б., Миронова О.Н. Оценка цервикального скрининга при лечении вульвовагинальной атрофии в пери- и постменопаузе // Гинекология. - 2016; 6: 32-5.
- IMS Recommendations on women’s midlife health and menopause hormone therapy // Climacteric. - 2016; 19: 109-50.
- Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста. Клинические рекомендации. Под ред. Л.В. Адамян, В.Н. Серова, Г.Т. Сухих, О.С. Филиппова // Проблемы репродукции (спец. вып.). - 2015; 6 (21): 451-9.
Supplementary files
